To investigate the safety and efficacy of a skincare regimen in individuals with mild to moderate acne and sensitive skin. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4.
The main questions this study aims to answer are:
1. To investigate the safety of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 2. To determine the efficacy of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 3. To assess the participants' satisfaction with the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.
Healthy Malaysian women and men
Fitzpatrick skin type II-V
Age above 18 years old
Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
Pregnant or breastfeeding women, or those planning pregnancy during the study period.
Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to topical products.
Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.